Addus HomeCare (NASDAQ:ADUS) Price Target Increased to $128.00 by Analysts at TD Cowen

Addus HomeCare (NASDAQ:ADUSFree Report) had its price objective boosted by TD Cowen from $119.00 to $128.00 in a research report report published on Tuesday, Benzinga reports. They currently have a buy rating on the stock.

A number of other brokerages also recently issued reports on ADUS. Royal Bank of Canada reissued an outperform rating and set a $102.00 price objective on shares of Addus HomeCare in a research report on Thursday, February 29th. Bank of America upped their price objective on Addus HomeCare from $115.00 to $118.00 and gave the stock a buy rating in a research note on Tuesday, May 7th. StockNews.com raised Addus HomeCare from a buy rating to a strong-buy rating in a research note on Thursday, June 6th. Barclays downgraded Addus HomeCare from an equal weight rating to an underweight rating and set a $83.00 price target for the company. in a research note on Tuesday, April 23rd. Finally, Stephens raised their price objective on Addus HomeCare from $120.00 to $128.00 and gave the company an overweight rating in a research report on Friday, May 31st. One equities research analyst has rated the stock with a sell rating and eight have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of Moderate Buy and a consensus price target of $113.43.

Check Out Our Latest Report on ADUS

Addus HomeCare Price Performance

NASDAQ ADUS opened at $118.45 on Tuesday. The stock has a market capitalization of $1.94 billion, a price-to-earnings ratio of 29.39, a PEG ratio of 2.28 and a beta of 1.02. Addus HomeCare has a 1-year low of $78.35 and a 1-year high of $119.98. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.35 and a quick ratio of 1.35. The business’s fifty day moving average price is $107.61 and its 200-day moving average price is $98.98.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last posted its quarterly earnings data on Monday, May 6th. The company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $0.97 by $0.24. The company had revenue of $280.70 million during the quarter, compared to analysts’ expectations of $279.49 million. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. Addus HomeCare’s revenue for the quarter was up 11.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.84 earnings per share. On average, equities analysts predict that Addus HomeCare will post 4.36 earnings per share for the current year.

Insider Transactions at Addus HomeCare

In related news, EVP Roberton James Stevenson sold 217 shares of the stock in a transaction dated Monday, June 17th. The shares were sold at an average price of $116.13, for a total value of $25,200.21. Following the completion of the transaction, the executive vice president now owns 10,217 shares of the company’s stock, valued at approximately $1,186,500.21. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 4.60% of the company’s stock.

Institutional Trading of Addus HomeCare

A number of institutional investors have recently bought and sold shares of ADUS. Louisiana State Employees Retirement System purchased a new stake in shares of Addus HomeCare in the fourth quarter valued at $752,000. Dean Capital Management bought a new stake in Addus HomeCare in the fourth quarter worth about $652,000. Hsbc Holdings PLC boosted its position in shares of Addus HomeCare by 2.9% during the third quarter. Hsbc Holdings PLC now owns 41,578 shares of the company’s stock valued at $3,542,000 after buying an additional 1,177 shares during the period. Allianz Asset Management GmbH bought a new position in shares of Addus HomeCare during the fourth quarter valued at approximately $5,667,000. Finally, Cetera Trust Company N.A purchased a new stake in shares of Addus HomeCare in the fourth quarter worth approximately $219,000. 95.35% of the stock is currently owned by institutional investors.

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

See Also

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.